| Title |
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, December 2018
|
| DOI | 10.1186/s40425-018-0479-7 |
| Pubmed ID | |
| Authors |
Saman Maleki Vareki |
X Demographics
The data shown below were collected from the profiles of 120 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 42 | 35% |
| Spain | 19 | 16% |
| Sweden | 3 | 3% |
| France | 3 | 3% |
| Italy | 3 | 3% |
| Argentina | 2 | 2% |
| Japan | 2 | 2% |
| Canada | 2 | 2% |
| India | 2 | 2% |
| Other | 11 | 9% |
| Unknown | 31 | 26% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 72 | 60% |
| Scientists | 31 | 26% |
| Practitioners (doctors, other healthcare professionals) | 16 | 13% |
| Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 425 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 425 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 72 | 17% |
| Researcher | 65 | 15% |
| Student > Master | 59 | 14% |
| Student > Bachelor | 41 | 10% |
| Other | 26 | 6% |
| Other | 38 | 9% |
| Unknown | 124 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 89 | 21% |
| Medicine and Dentistry | 69 | 16% |
| Immunology and Microbiology | 52 | 12% |
| Agricultural and Biological Sciences | 27 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 4% |
| Other | 34 | 8% |
| Unknown | 139 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 139. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2024.
All research outputs
#307,380
of 25,931,626 outputs
Outputs from Journal for Immunotherapy of Cancer
#57
of 3,539 outputs
Outputs of similar age
#6,568
of 448,286 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#2
of 80 outputs
Altmetric has tracked 25,931,626 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,539 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,286 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.